DIGITAL TRANSFORMATION

 

 

How do we change pharma from the ground up. Digital Transformation is the way, but it is fraught with challenges to adoption. Here we will explore culture and trail blazing examples of adoption in pharma and healthcare.  

THIS YEAR’S WORLD LEADING DIGITAL TRANSFORMATION SPEAKERS

 

 

 

Digital Transformation, Tuesday 2 November 2021

08:40

Opening Remarks

Trevor Howe
09:00

Looking at the bigger picture: How do we make sure that we have the full picture with big data experiments

Joachim Reischl
09:20

Deep Medicine – towards the next generation of software-based precision medicine diagnostics

  • Evolution of precision medicine
  • AI in predicting clinical outcome
  • Software as Medical Device as Companion Diagnostic
Panel discussion
09:40

Essential Tools for Accelerating Pipeline Productivity & Success

What tools are in your toolkit? Join this leading biopharma panel discussion to find out how to give your AI-based drug discovery and development program a competitive edge and increase program success.
10:40

Networking Break

Amrik Mahal
Digital Transformation
11:40

Digital Transformation across the R&D Value Chain

Digital Transformation
12:00

L7 Informatics

Boris Adryan
Digital Transformation
12:20

Upskilling Your Workforce to Enable Digital Transformation From the Ground Up – Culture and Implementation

Gaurav Agrawal
Digital Transformation
12:40

Assessing Digital Maturity: The First Step towards your R&D Informatics Strategy

Christoph Huels
Digital Transformation
13:00

Digitalizing Pharma Production – 3D Printing of Tablets

  • 3D printing technologies are on the rise for production of tablets (oral dosage forms)
  • This leads to a more flexible, faster and simpler clinical trial and later commercial supply
  • The technology enables digitalized and decentralized pharma production
13:20

Networking Lunch Break

Panel discussion
Digital Transformation
14:20

What are the next stages of digital transformation in Pharmaceuticals?

Moderator: Fareed. Mirza, Global Head of Data Alliances, AstraZeneca
Digital Transformation
15:00

CAMBRIDGE COGNITION

Francesca Wuttke
Digital Transformation
15:20

Digital Therapeutics at Almirall

Ali Torkamani
Digital Transformation
15:40

MyGeneRank: Digital Trials and Genetic Risk Scores

  • Our approach to the de-centralized, real-world, and participant-centric approach to validating the utility of polygenic risk scores via MyGeneRank.
  • Results of our first trial in coronary artery disease
  • Future plans for further validation of predictive genomics techniques.
Catherine Brownstein
Digital Transformation
16:00

Long-Range Optical Genome Mapping at a Tertiary Children’s Hospital

  • Introduction to Bionano Saphyr technology applications at a children’s hospital
  • Case examples of Bionano Saphyr usage
  • Integrating care and discovery using optical genome mapping
16:20

Networking Break

Digital Transformation
17:00

Benchling Reserved

18:00

Neri & Sons Band & Networking Drinks Reception

last published: 27/Jul/21 14:25

Digital Transformation, Wednesday 3 November 2021

Steffen Roellinger
09:00

Decentralised Clinical Trials

  • Discussing the adoption of decentralised clinical trials at Bayer
  • New digital addoption
  • The Bayer trials transformaiton over COVID-19
Andrew Kasarskis
09:00

Digital transformation over COVID-19 – Challenges for the future and perpetuating the efforts

  • COVID-19 lead to digital innovation by necessity, including telehealth, new apps and digital technologies, and data fusion and sharing advances.
  • Large opportunities exist to do much better with learning from data, however.This requires the following operational and cultural change:
-Proactive collection and use of coherent data sets as a baseline for public health and the infrastructure development to support that work.-Recommitment to evidence-based medicine and timely, rigorous assessment of clinical utility through ongoing clinical research with well-powered studies of strong statistical design coupled to careful monitoring of large observational data.
Said Ismail
09:20

Qatar Genome; Big data from an underrepresented region

  • Overview of the Qatar Genome Project (QGP)
  • Contributions to Middle East Genomics
  • QGP role COVID-19 research
  • Strategy for precision medicine implementation
09:20

SevenBridges

Panel discussion
09:40

BC Platforms - Keynote Panel

Paul Agapow
09:40

How to be right: effective use of clinical models and machine learning in the clinic

    There is an increasing demand for a sophisticated model to predict patient outcomes and suggest treatmentsUnfortunately, most proposed clinical models are not fit for purpose, being biased, unvalidated, or irrelevantHere we suggest best practices for the development and deployment of complex ML algorithms, resulting in more successful and effective models
10:20

Networking Break + Speed Networking

Digital Transformation
11:15

Chair's Remarks

Digital Transformation
11:40

Pangaea

Michael Seewald
Digital Transformation
12:00

Transforming Healthcare Delivery with Evidence and Data

Andy Phillips
Digital Transformation
12:20

Business Cases for Digital Transformation

Dimitris Agrafiotis
Digital Transformation
12:40

Accurate prediction of clinical stroke scales and improved biomarkers of motor impairment from robotic measurements

13:00

Networking Lunch Break

Panel discussion
Digital Transformation
14:00

The CDO Panel Digital Transformation from The Top – Empowering an Industry

  • What are the roadblocks to achieving digital transformation in pharmaceuticals?
  • How do you accelerate the change process?
  • Lessons learnt from other industries – how to translate them?
  • As an audience member how can you help?
Moderator: Julie Huxley-Jones, VP of Research Solutions, GlaxSmithKline
Mariam Shokralla
Digital Transformation
14:40

Global Digital Transformation Digital Health and the WHO

Yannis Pandis
Digital Transformation
15:00

Implementation of Digital Solutions in IMI IDEA-FAST

  • IDEA-FAST aims to identify digital endpoints that provide reliable, objective and sensitive evaluation of activities of daily life (ADL), disability and health related-quality of life (HRQoL)
  • The study focuses on Parkinson’s Disease (PD), Huntington’s Disease (HD) (IMID): Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Primary Sjögren’s Syndrome (PSS), and Inflammatory Bowel Disease (IBD)
Giuseppe Sollazzo
Digital Transformation
15:20

Accelerating AI in the UK healthcare system: the NHS AI Lab and the Skunkworks experience

  • The NHSX and AI Lab story
  • Successes of the AI Lab
  • The Skunkworks model
David Herzig
Digital Transformation
15:40

Using Augmented Reality as a Digital Therapeutic

16:00

Networking Break

Andrew Hardy
Digital Transformation
17:00

Strategic Decision Making Using the Digital Twin

18:00

Drinks Reception

last published: 27/Jul/21 14:25

Digital Transformation, Thursday 4 November 2021

Scott Chandler
09:00

Genetic Drivers of Response to Immunotherapy: Going Beyond the Tumor

09:20

GenomeSys

Thomas Hach
10:40

The Future of Precision Healthcare – Multi-Omics Humanized

  • Personalization of healthcare, not only of drug treatment, is the future
  • Patient influence, patient data and patient-desired outcomes are the most disruptive factors
  • How can we move from sterile biosignatures to a humanized approach?
last published: 27/Jul/21 14:25

GET INVOLVED AT BIODATA WORLD CONGRESS

 

 

TO SPONSOR


Alistair Wilmot
alistair.wilmot@terrapinn.com
0207 092 1174

 

 

TO SPEAK


Edward Glanville

edward.glanville@terrapinn.com
0207 092 1042

 

 

MARKETING OPPORTUNITIES


Onika Akhtar
onika.akhtar@terrapinn.com
0207 092 1034